Avigan – favipiravir is the generic name – a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. Photo: Reuters
China and South Korea split over Japanese anti-flu drug Avigan in fight against coronavirus
- Favipiravir emerges as a potential drug to treat Covid-19 patients but worries over risks to fetus remain
- Shinzo Abe has promoted the drug to Donald Trump but FDA ‘concerned’
Topic |
Coronavirus pandemic
Avigan – favipiravir is the generic name – a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. Photo: Reuters